Mylan and Biocon present clinical data on Insulin Glargine at ADA
Data shows comparable efficacy, safety and immunogenicity to Lantus in Type I and Type II Diabetes Patients
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.